| Title | Author(s) | Year | View Count |  | Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene? | Dorfman, R; Nalpathamkalam, T; Taylor, C; Gonska, T; Keenan, K; Yuan, XW; Corey, M; Tsui, LC; Zielenski, J; Durie, P | 2010 | 45 |
| Modifier gene study of meconium ileus in cystic fibrosis: Statistical considerations and gene mapping results | Dorfman, R; Li, W; Sun, L; Lin, F; Wang, Y; Sandford, A; Paré, PD; McKay, K; Kayserova, H; Piskackova, T; MacEk, M; Czerska, K; Sands, D; Tiddens, H; Margarit, S; Repetto, G; Sontag, MK; Accurso, FJ; Blackman, S; Cutting, GR; Tsui, LC; Corey, M; Durie, P; Zielenski, J; Strug, LJ | 2009 | 130 |
 | Complex two-gene modulation of lung disease severity in children with cystic fibrosis | Dorfman, R; Sandford, A; Taylor, C; Huang, B; Frangolias, D; Wang, Y; Sang, R; Pereira, L; Sun, L; Berthiaume, Y; Tsui, LC; Paré, PD; Durie, P; Corey, M; Zielenski, J | 2008 | 159 |
| Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials | Wilschanski, M; Dupuis, A; Ellis, L; Jarvi, K; Zielenski, J; Tullis, E; Martin, S; Corey, M; Tsui, LC; Durie, P | 2006 | 1,412 |
| The prevalence and clinical characteristics of cystic fibrosis in South Asian Canadian immigrants | MeiZahav, M; Durie, P; Zielenski, J; Solomon, M; Tullis, E; Tsui, LC; Corey, M | 2005 | 858 |
 | Glucose intolerance in children with cystic fibrosis | Solomon, MP; Wilson, DC; Corey, M; Kalnins, D; Zielenski, J; Tsui, LC; Pencharz, P; Durie, P; Sweezey, NB | 2003 | 430 |
| Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas | Ahmed, N; Corey, M; Forstner, G; Zielenski, J; Tsui, LC; Ellis, L; Tullis, E; Durie, P | 2003 | 352 |
| Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis | Durno, C; Corey, M; Zielenski, J; Tullis, E; Tsui, LC; Durie, P | 2002 | 182 |
| Cystic fibrosis gene mutations and infertile men with primary testicular failure | Mak, V; Zielenski, J; Tsui, LC; Durie, P; Zini, A; Martin, S; Longley, TB; Jarvi, KA | 2000 | 416 |
| Mutations in the cystic fibrosis transmembrane regulator gene in patients with tropical calcific pancreatitis [8] | Bhatia, E; Durie, P; Zielenski, J; Lam, D; Sikora, SS; Choudhuri, G; Tsui, LC | 2000 | 86 |
| Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia | Mak, M; Zielenski, J; Tsui, LC; Durie, P; Zini, A; Martin, S; Longley, TB; Jarvi, KA | 1999 | 469 |
| Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13 [3] | Zielenski, J; Corey, M; Rozmahel, R; Markiewicz, D; Aznarez, I; Casals, T; Larriba, S; Mercier, B; Cutting, GR; Krebsova, A; Macek M, Jr; Langfelder Schwind, E; Marshall, BC; DecelieGermana, J; Claustres, M; Palacio, A; Bal, J; Nowakowska, A; Ferec, C; Estivill, X; Durie, P; Tsui, LC | 1999 | 130 |
| Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: Role of cystic fibrosis transmembrane conductance regulator gene mutations | Jarvi, K; McCallum, S; Zielenski, J; Durie, P; Tullis, E; Wilchanski, M; Margolis, M; Asch, M; Ginzburg, B; Martin, S; Buckspan, MB; Tsui, LC | 1998 | 254 |
| Defining the modifiers of CF pathophysiology | Rozmahel, R; Nguyen, V; Corey, M; Haston, CK; Kent, G; Bear, C; Durie, P; Tsui, LC | 1998 | 97 |
| Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens | Mak, V; Jarvi, KA; Zielenski, J; Durie, P; Tsui, LC | 1997 | 386 |
| Incomplete rescue of cystic fibrosis transmembrane conductance regulator deficient mice by the human CFTR cDNA | Rozmahel, R; Gyömörey, K; Plyte, S; Nguyen, V; Wilschanski, M; Durie, P; Bear, CE; Tsui, LC | 1997 | 429 |
| Genotype and phenotype in cystic fibrosis | Tsui, LC; Durie, P | 1997 | 66 |
| In vivo measurements of ion transport in long-living CF mice | Wilschanski, MA; Rozmahel, R; Beharry, S; Kent, G; Li, C; Tsui, LC; Durie, P; Bear, CE | 1996 | 239 |
| Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor | Rozmahel, R; Wilschanski, M; Matin, A; Plyte, S; Oliver, M; Auerbach, W; Moore, A; Forstner, J; Durie, P; Nadeau, J; Bear, C; Tsui, LC | 1996 | 292 |
| Erratum: Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor (Nature Genetics (1996) 12 (280-287)) | Rozmahel, R; Wilschanski, M; Matin, A; Plyte, S; Oliver, M; Auerbach, W; Moore, A; Forstner, J; Durie, P; Nadeau, J; Bear, C; Tsui, LC | 1996 | 43 |
|
